Suppr超能文献

[卡比马唑治疗格雷夫斯病期间血清甲状腺激素及TSH对促甲状腺激素释放激素的反应(作者译)]

[Serum thyroid hormones and TSH response to TRH during treatment of Graves' disease by carbimazole (author's transl)].

作者信息

Lorcy Y, Heim J, Auvray E, Allannic H

出版信息

Ann Endocrinol (Paris). 1979 Jul-Aug;40(4):441-2.

PMID:117739
Abstract

Serum concentrations of Thyroxine (T4), triiodothyronine (T3) free thyroxine index (F.T.I.) and TSH response to TRH were evaluated in 55 Graves' diseases treated by Carbimazole. There is a good correlation between serum thyroid hormones and clinical state: 83,7% for T4; 79,5% for T3; on the other hand there is a discrepancy between T3 and T4 in many cases and between delta TSH and T4 (47%) or T3 (46%). The decrease of T4 occurs before that of T3: 46,6% normal at the 4th month and 72,5% at the 9th month for T4 against 41% and 50% for T3. At the end of the treatment 96,4% of patients are clinically normal but 20% of them remain with T3 and T4 values above normal.

摘要

对55例接受卡比马唑治疗的格雷夫斯病患者的血清甲状腺素(T4)、三碘甲状腺原氨酸(T3)、游离甲状腺素指数(F.T.I.)以及促甲状腺激素(TSH)对促甲状腺激素释放激素(TRH)的反应进行了评估。血清甲状腺激素与临床状态之间存在良好的相关性:T4为83.7%;T3为79.5%;另一方面,在许多情况下,T3与T4之间以及促甲状腺激素变化量(ΔTSH)与T4(47%)或T3(46%)之间存在差异。T4的下降先于T3:治疗第4个月时T4正常的比例为46.6%,第9个月时为72.5%,而T3在第4个月和第9个月时正常的比例分别为41%和50%。治疗结束时,96.4%的患者临床症状正常,但其中20%的患者T3和T4值仍高于正常水平。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验